Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy?

Detalles Bibliográficos
Autores principales: López-Medrano, Francisco, Aguado, José María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310784/
https://www.ncbi.nlm.nih.gov/pubmed/34325068
http://dx.doi.org/10.1016/j.cmi.2021.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310784/
https://www.ncbi.nlm.nih.gov/pubmed/34325068
http://dx.doi.org/10.1016/j.cmi.2021.07.012

Ejemplares similares